Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 6, 2020
- Accepted for publication April 24, 2020
- Published online December 17, 2020.
Article Versions
- previous version (May 22, 2020 - 14:43).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Mathias Loft1,2,
- Esben A. Carlsen1,2,
- Camilla B. Johnbeck1,2,
- Helle H. Johannesen1,2,
- Tina Binderup1,2,
- Andreas Pfeifer1,2,
- Jann Mortensen1,2,
- Peter Oturai1,2,
- Annika Loft1,2,
- Anne K. Berthelsen1,2,
- Seppo W. Langer2,3,
- Ulrich Knigge2,4 and
- Andreas Kjaer1,2
- 1Department of Clinical Physiology, Nuclear Medicine, and PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
- 2ENETS Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Copenhagen, Denmark
- 3Department of Oncology, Rigshospitalet, Copenhagen, Denmark; and
- 4Departments of Clinical Endocrinology and Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark
- For correspondence or reprints contact: Andreas Kjaer, Department of Clinical Physiology, Nuclear Medicine, and PET, KF-4011, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail: akjaer{at}sund.ku.dk
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans
- Efficacy of [67Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2-Positive Neuroendocrine Tumors
- An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
- An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
- SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors
- Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume
- Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects